EUVIMEDEUVIMED entdecken
Crossref

Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective

Kun Shi-van Wielink, Annegret Dahlmann-Noor, Jieyi Li, Thom W L de Milliano, Frederic Ernst, Francesco Croci, Yuvraj Sharma, Yogesh Punekar

PharmacoEconomics · 2026-09 · 44 (9) · 1057-1075

DOI: 10.1007/s40273-026-01630-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PharmacoEconomics, online erschienen am 02.06.2026. Verfasst von Kun Shi-van Wielink und 7 weiteren Autor:innen. Beteiligte Einrichtung: Santen Pharmaceutical SA, the Netherlands Branch, De Entree 11-97, 1101BH, Amsterdam, Netherlands. kun.shivanwielink@santen.com. Hauptthemen laut MEDLINE: Atropine, Myopia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 136 Literaturangaben. Gefördert von: Santen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtropineMyopiaHumansCost-Benefit AnalysisCost-Effectiveness AnalysisUnited KingdomChildOphthalmic SolutionsQuality-Adjusted Life YearsCohort StudiesStandard of CareDisease ProgressionModels, Economic

Substanzen

AtropineOphthalmic Solutions

Autor:innen und Institutionen

  • Santen Pharmaceutical SA, the Netherlands Branch, De Entree 11-97, 1101BH, Amsterdam, Netherlands. kun.shivanwielink@santen.com.
  • NIHR Moorfields Biomedical Research Centre, London, UK.
  • University College London, London, UK.
  • Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Santen Pharmaceutical SA, the Netherlands Branch, De Entree 11-97, 1101BH, Amsterdam, Netherlands.
  • Santen Pharmaceuticals SA, Geneva, Switzerland.

Förderung

  • Santen

Zitieren

APA

Wielink, K. S., Dahlmann-Noor, A., Li, J., de Milliano, T. W. L., Ernst, F., Croci, F., Sharma, Y., & Punekar, Y. (2026). Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective. PharmacoEconomics, 44(9), 1057-1075. https://doi.org/10.1007/s40273-026-01630-3

Vancouver

Wielink KS, Dahlmann-Noor A, Li J, de Milliano TWL, Ernst F, Croci F, et al. Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective. PharmacoEconomics. 2026;44(9):1057-1075. doi:10.1007/s40273-026-01630-3

BibTeX
@article{Wielink2026,
  author = {Wielink, Kun Shi-van and Dahlmann-Noor, Annegret and Li, Jieyi and de Milliano, Thom W L and Ernst, Frederic and Croci, Francesco and Sharma, Yuvraj and Punekar, Yogesh},
  title = {Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective},
  journal = {PharmacoEconomics},
  year = {2026},
  volume = {44},
  number = {9},
  pages = {1057--1075},
  doi = {10.1007/s40273-026-01630-3}
}
Kostenlos starten →